| For: | Yang Y, Chen Y, Tang JY, Chen J, Li GQ, Feng B, Mu J. MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice via downregulation of DNA methyl transferase 3A and 3B. World J Diabetes 2025; 16(4): 93630 [PMID: 40236856 DOI: 10.4239/wjd.v16.i4.93630] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i4/93630.htm |
| Number | Citing Articles |
| 1 |
Shengnan Lin, Zheng Shu, Mi Zhou, Zhen Jia, Tianshu Wei, Xiaojun Zhou. Inflammatory mechanisms in diabetic nephropathy: emerging insights and targeted therapeutics. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1722159
|
| 2 |
Qian Liu, Xuanxuan Jiao, Tongdao Xu, Chuanmei He, Fang Yang, Fumeng Yang. Potential of circulating miR-29a and miR-142-5p as biomarkers for diabetic nephropathy: a cross-sectional study. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1804671
|
| 3 |
Xiaoyan Zhu, Lulu Lian. Identification of Key Genes in Diabetic Retinopathy Using Bioinformatics and Machine Learning Approaches. Cureus 2025; doi: 10.7759/cureus.99936
|
| 4 |
Mahboube Bahroudi, Mastaneh Moghtaderi. Therapeutic Potential of Mesenchymal Stem Cells in Pediatric Kidney Disorders: A Comprehensive Review. Health Science Reports 2026; 9(2) doi: 10.1002/hsr2.71769
|
| 5 |
Shengnan Zhang, Shupeng Dai, Chenxia Lu, Li Li, Yuxingchun Wu, Mi Chen. Role of the DNA methyltransferases in diabetes mellitus and Its complications. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-12003-6
|
| 6 |
Marwa A. Dahpy, Marwa K. Khairallah, Rania Naguib, Mona A. Khalil, Salwa Seif Eldin, Marwa A. Sabet, Amira A. Kamel. Investigating circulating expression profile for H19, MEG3, and MIAT long noncoding RNAs with miR-135a and miR-29a in chronic kidney disease and renal hemodialysis patients: interrelations with serum sclerostin. Frontiers in Molecular Biosciences 2026; 12 doi: 10.3389/fmolb.2025.1703108
|